statistiche ricercatore

Nome	#
Reversible Cognitive Frailty, Dementia, and All-Cause Mortality. The Italian Longitudinal Study on Aging	146
Fingolimod versus interferon beta/glatiramer acetate after natalizumab suspension in multiple sclerosis	131
The use of immunosuppressant therapy for multiple sclerosis in Italy: A multicenter retroprospective study	96
Daily Function as Predictor of Dementia in Cognitive Impairment, No Dementia (CIND) and Mild Cognitive Impairment (MCI): An 8-Year Follow-Up in the ILSA Study	88
null	74
null	65
Detection of disability worsening in relapsing-remitting multiple sclerosis patients. A real-world roving EDSS-Expanded Disability Status Scale reference analysis from the Italian Multiple Sclerosis Register	58
Clinical effectiveness of different natalizumab interval dosing schedules in a large Italian population of patients with multiple sclerosis	47
null	44
PML risk is the main factor driving the choice of discontinuing natalizumab in a large multiple sclerosis population: results from an Italian multicenter retrospective study	39
Isoelectric focusing and crossed immunoelectrofocusing of cerebrospinal fluid proteins in neurological disorders	24
Incidence of amyotrophic lateral sclerosis in southern Italy: a population based study	20
null	18
Data monitoring roadmap. The experience of the Italian Multiple Sclerosis and Related Disorders Register	12
Progression independent of relapse activity in relapsing multiple sclerosis: impact and relationship with secondary progression	4
Totale	866

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2019/2020	139	0	0	0	0	22	13	15	19	19	16	30	5
2020/2021	147	6	6	17	38	11	12	2	13	6	17	8	11
2021/2022	97	6	4	6	2	6	10	4	7	5	8	17	22
2022/2023	143	18	23	13	6	17	23	1	15	22	0	3	2
2023/2024	72	2	10	7	17	10	13	1	1	1	2	1	7
2024/2025	52	13	4	16	16	3	0	0	0	0	0	0	0
Totale													866